Publications by authors named "H Veeze"
Background: Complexity of glucose regulation in persons with type 1 diabetes (PWDs) necessitates increased automation of insulin delivery (AID). This study aimed to analyze real-world data over 12 months from PWDs who started using the MiniMed 780G (MM780G) advanced hybrid closed-loop (aHCL) AID system at the Diabeter clinic, focusing on glucometrics and clinical outcomes.
Methods: Persons with type 1 diabetes switching to the MM780G system were included.
Article Synopsis
- * The study involved a prospective cohort of 611 participants aged 16 and older with at least 5 years of T1D, plus a second group of 160 participants with a minimum of 35 years of T1D, gathering a range of health data, physical assessments, and biological samples.
- * Preliminary findings indicate that additional C-peptide secretion was noted in 10% of individuals, linking fasting C-peptide levels with reduced hypoglycemia awareness
Objective: To examine the prevalence, time trends, and risk factors of diabetic retinopathy (DR) among youth with type 1 diabetes (T1D) from 11 countries (Australia, Austria, Denmark, England, Germany, Italy, Luxemburg, Netherlands, Slovenia, United States, and Wales).
Subjects And Methods: Data on individuals aged 10-21 years with T1D for >1 year during the period 2000-2020 were analyzed. We used a cross-sectional design using the most recent year of visit to investigate the time trend.
Article Synopsis
- Cardiovascular disease is the main cause of death for individuals with type 1 diabetes, highlighting the importance of managing cardiovascular risks as part of their treatment.
- The study assessed how well lipid and blood pressure management were implemented among individuals with type 1 diabetes, following guidelines from Dutch, ADA, and NICE over a one-year period.
- Results showed low prescription rates for lipid-lowering and antihypertensive medications, especially in younger patients, with many failing to meet recommended treatment targets.
Article Synopsis
- The study explores how glycemic variability (GV) affects pregnancy complications in women with type 1 diabetes during the pre- and periconception period, highlighting a gap in existing knowledge.
- Among 63 eligible women, 29 were included as their glucose data were analyzed through various metrics, revealing that a higher Average Daily Risk Range (ADRR) at conception correlated with greater complication scores.
- The findings suggest that the relationship between GV and complications varies based on the timing during pregnancy and the specific measurement metrics used.